Atabak Mokari - Feb 13, 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Financial Officer
Signature
/s/ Joseph Douglas Lyon, as attorney in fact for Atabak Mokari
Stock symbol
CORT
Transactions as of
Feb 13, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2023, 06:59 PM
Previous filing
Feb 11, 2022
Next filing
Sep 6, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable ratably in equal installments on each monthly anniversary of February 13, 2023 over a four-year period.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.